Emotional Resolution therapy for anxiety in healthcare workers
CalmER Intervention Trial for Healthcare Workers With Anxiety
This study is testing whether Emotional Resolution therapy can help reduce anxiety in healthcare workers who have been under a lot of stress during the pandemic.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 150 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of California, Los Angeles Academic / other |
| Locations | 1 site (Los Angeles, California) |
| Trial ID | NCT06460285 on ClinicalTrials.gov |
What this trial studies
This study tests the effectiveness of Emotional Resolution (EmRes) therapy in reducing anxiety among healthcare workers, who have faced significant mental health challenges, especially during the COVID-19 pandemic. Participants will engage in 6-8 sessions of EmRes therapy delivered via Zoom, compared to an active control group practicing mindfulness-based gratitude. The study aims to provide a more accessible and effective therapeutic option for those struggling with anxiety, particularly in the healthcare sector. By exploring new therapeutic techniques, the study seeks to address the high levels of anxiety and burnout experienced by healthcare professionals.
Who should consider this trial
Good fit: Ideal candidates are healthcare workers over 18 years old, fluent in English, and experiencing moderate to severe anxiety.
Not a fit: Patients currently on anxiety medications or those with a GAD score below 5 may not benefit from this study.
Why it matters
Potential benefit: If successful, this therapy could provide an effective and accessible treatment option for healthcare workers suffering from anxiety.
How similar studies have performed: While the approach of using EmRes therapy is relatively novel, similar studies exploring emotion regulation techniques have shown promise in improving mental health outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Must be able to provide written informed consent 2. \> 18 years of age at Visit 3. Fluent in English 4. Current healthcare worker in a hospital 5. Generalized anxiety disorder (GAD) score of \> 5 Exclusion Criteria: 1. Unable to provide written informed consent 2. Under the age of 18 3. Not fluent in English 4. Not working as a healthcare worker in a hospital 5. GAD score \< 5 6. Currently on anxiety medication (Beta Blockers or Benzodiazepines)
Where this trial is running
Los Angeles, California
- University of California, Los Angeles — Los Angeles, California, United States (Recruiting)
Study contacts
- Study coordinator: Summer Mengelkoch, PhD
- Email: smengelkoch@mednet.ucla.edu
- Phone: 7632322908
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.